Recent news and posts
Ongoing mini-HTAs of medical technologies in Norway
Norway established in 2013 a framework for the introduction of innovations into the health care system through either a national or hospital-based health technology assessment. This framework is called the “New Method.”
In this framework, all innovations should undergo HTA before being funded. If the method concerns only one or two hospitals, the assessment shall be initiated by clinicians and ran at the hospital level. The final report is disseminated via a mini-HTA database. If the method is of national concern, it undergoes Single Technology Appraisal at national level followed by the funding decision by the group of payers (Decision Forum, Beslutningsforum).
As of February 2019, there are 13 ongoing mini-HTA projects:
- Delirium tremens (alcohol slate) – prevention (Oslo University Hospital)
- Neurovascular structure-adjacent frozen-section (NeuroSAFE) during robot-assisted laparoscopic prostatectomy (RALP) (Oslo University Hospital)
- Intraepidermal nerve fiber density (IENFD) in skin biopsy (Oslo University Hospital)
- Patient-centered services for transitions from hospital to home (Oslo University Hospital)
- Robot-assisted minimally invasive harvesting of muscle patches for reconstructive surgery (Oslo University Hospital)
- Stockholm3 test (Stavanger Hospital Trust)
- Implementation of focused ultrasound in emergency departments (Akershus University Hospital)
- Nitrous oxide (Bergen Hospital Trust)
- Tonsillectomy with Bizact device (Akershus University Hospital)
- Cacicol (eye drops) for corneal ulcer (Innlandet Hospital Trust)
- Establishment of local and regional intensive services for children and young people with multifunctional disabilities (Møre og Romsdal Hospital Trust)
- Microwave ablation of lung cancer and lung metastases (Bergen Hospital Trust)
- Use of PET-CT for mapping of cardiac ischemia (Stavanger Hospital Trust)
The full list (in Norwegian) can be seen here.
After completion of the assessment, hospital management will make a decision about funding of studied technology in a particular hospital.
Subscribe to our newsletter delivered every second week not to miss important reimbursement information.